ES8105146A1 - Un procedimiento para la preparacion de una solucion liquidainyectable de una sulfonamida - Google Patents

Un procedimiento para la preparacion de una solucion liquidainyectable de una sulfonamida

Info

Publication number
ES8105146A1
ES8105146A1 ES493006A ES493006A ES8105146A1 ES 8105146 A1 ES8105146 A1 ES 8105146A1 ES 493006 A ES493006 A ES 493006A ES 493006 A ES493006 A ES 493006A ES 8105146 A1 ES8105146 A1 ES 8105146A1
Authority
ES
Spain
Prior art keywords
approximately
solution
long acting
injectable compositions
sulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493006A
Other languages
English (en)
Other versions
ES493006A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES493006A0 publication Critical patent/ES493006A0/es
Publication of ES8105146A1 publication Critical patent/ES8105146A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA SOLUCION LIQUIDA INYECTABLE DE UNA SULFONAMIDA. COMPRENDE: A) COMBINAR CON AGUA 2-PIRROLIDONA A N-METILPIRROLIDONA Y, SI SE DESEA, AÑADIR POLIVINILPIRROLIDONA, PROPILENGLICOL, UN POLIETILENGLICOL, ALCOHOL BENCILICO, DIMETILACETAMIDA, LACTATO DE ETILO O GLICEROL-FORMAL; B) AGREGAR A LA DISOLUCION PROCEDENTE DE LA ETAPA ANTERIOR LA SULFADIMETOXINA O LA SULFAMETAZINA; C) AJUSTA EL PH DE LA DISOLUCION PROCEDENTE DE LA ETAPA ANTEROR, SI ES NECESARIO, A UN VALOR DE 5 A 9,5 APROXIMADAMENTE. LA POLIVINILPIRROLIDONA, CON UN PESO MOLECULAR PROMEDIO DE 5.000 A 100.000, ESTA PRESENTE EN UNA CONCENTRACION DE 1 A 5 POR 100 P/V, APROXIMADAMENTE, Y EL PROPILENGLICOL, UN POLIETILENGLICOL, ALCOHOL BENCILICO, DIMENTILACETAMIDA, LACTATO DE ETILO O GLICEROL-FORMAL, A UNA CONCENTRACION DE 0,5 A 30 POR 100 P/V, APROXIMADAMENTE.
ES493006A 1979-07-02 1980-07-01 Un procedimiento para la preparacion de una solucion liquidainyectable de una sulfonamida Expired ES8105146A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5431379A 1979-07-02 1979-07-02

Publications (2)

Publication Number Publication Date
ES493006A0 ES493006A0 (es) 1981-06-01
ES8105146A1 true ES8105146A1 (es) 1981-06-01

Family

ID=21990197

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493006A Expired ES8105146A1 (es) 1979-07-02 1980-07-01 Un procedimiento para la preparacion de una solucion liquidainyectable de una sulfonamida

Country Status (10)

Country Link
EP (1) EP0021847B1 (es)
AT (1) ATE4166T1 (es)
DE (1) DE3064250D1 (es)
DK (1) DK283480A (es)
ES (1) ES8105146A1 (es)
FI (1) FI72650C (es)
GR (1) GR69205B (es)
IE (1) IE49934B1 (es)
NZ (1) NZ194192A (es)
ZA (1) ZA803937B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
CN102772422B (zh) * 2012-08-22 2014-03-26 郑州福源动物药业有限公司 一种长效复方磺胺二甲嘧啶、巴喹普林注射液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631779A1 (de) * 1976-07-15 1978-01-19 Basf Ag Sulfonamid-trimethoprim-loesungen
IL52533A (en) * 1977-07-15 1980-01-31 Abic Ltd Injectable chloramphenicol composition

Also Published As

Publication number Publication date
ES493006A0 (es) 1981-06-01
EP0021847A3 (en) 1981-08-12
GR69205B (es) 1982-05-07
IE801363L (en) 1981-01-02
ZA803937B (en) 1981-06-24
DK283480A (da) 1981-01-03
DE3064250D1 (en) 1983-08-25
ATE4166T1 (de) 1983-08-15
IE49934B1 (en) 1986-01-08
EP0021847B1 (en) 1983-07-20
EP0021847A2 (en) 1981-01-07
FI802096A7 (fi) 1981-01-03
FI72650C (fi) 1987-07-10
FI72650B (fi) 1987-03-31
NZ194192A (en) 1982-11-23

Similar Documents

Publication Publication Date Title
BR9306399A (pt) Composição farmacéutica para uso no tratamento de glaucoma
UA41937C2 (uk) Стабільна місцеводіюча ретиноідна композиція
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
ATE76748T1 (de) Arzneimittel fuer den bereich der mundhoehle.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
NO871199D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater med langvarige frigjoeringsegenskaper.
ES2154650T3 (es) Composicion que comprende una formulacion con factor de coagulacion viii, procedimiento para su preparacion y uso de un tensioactivo como estabilizador.
NZ225106A (en) Compositions which include amino acids, metabolites an electrolyte and ribose
NO930817D0 (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
ATE58292T1 (de) L-dopa enthaltendes arzneimittel.
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
ES2023880B3 (es) Agentes fijadores para el cabello.
PE20030696A1 (es) Brivudina estabilizada en formulaciones topicas
ES8105146A1 (es) Un procedimiento para la preparacion de una solucion liquidainyectable de una sulfonamida
DK516288A (da) Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
IE40661B1 (en) Novel tetracyclic piperidino derivatives
DE69013972D1 (de) Kosmetische Zusammensetzung.
DK72888A (da) Thionophosphonsyreestere, fremgangsmaader til deres fremstilling samt deres anvendelse som pesticider
JPS5750914A (en) Betamethasone external pharmaceutical
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
SE8001425L (sv) Cytostatiskt verkande lekemedel resp farmaceutiska beredningar
ES2149247T3 (es) Nuevos compuestos de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los incluyen.
NO882491L (no) Fremgangsmaate for fremstilling av anti-viralt farmasoeytisk preparat.